This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VVUS at https://www.zacks.com/ap/VVUS Keywords: Vivus, Earnings Report
In that article we said the following regarding VVUS stock: VVUS is currently range-bound between the 50-day and 200-day exponential moving averages. If a run-up in VVUS is to occur ahead of the EU approval decision, look for the stock price …
VIVUS stock (VVUS) has taken a hit following a downgrade by equities research analysts at Piper Jaffray. Analysts listed the stock as “underweight” in a research note to investors. Wall Street has watched the biopharmaceutical company …
The top performers on the NASDAQ Composite were Blink Charging Co …
Biotechnology fund iShares NASDAQ Biotechnology Index (IBB) was down 0.2%. VIVUS (VVUS) surged more than …
The average investor's response to VVUS's undesirable statistics is to drop the stock or even short it (you do not short a $2 stock without a good reason). But in this article, I wish to offer a contrarian view, one that seeks VVUS as undervalued.
To say the past couple of months have been uncharacteristically bullish for Vivus, Inc. (VVUS) would be a significant understatement. After spending the past two years losing more than 90% of its value, Vivus stock has rallied an …
The top performers on the NASDAQ Composite were Blink Charging Co …